Navigation Links
Resistant Influenza strains creates panic in US

Rick A. Bright, an immunologist at the U.S. Centers for Disease Control and Prevention said that all samples of seasonal influenza virus this year have developed // resistance to adamantanes, the class of drugs which is used for the treatment for flu infection.

Drugs belonging to this class like amantadine and rimantadine are ineffectual for now and for the foreseeable future and shouldn't be used.

The findings were reported in the Journal of the American Medical Association. Amantadine and rimantadine were the pivotal drugs used against influenza A.

Statistics show that about 10-15% of the U.S. population suffers due to flu every year, and about 31,000 people die of it. Vaccination is considered the best strategy to prevent infection.

It was found that 91% of the 120 influenza a virus samples that were tested were resistant to these two drugs.

Presently a total of 209 influenza isolates (including the original 120) from 26 states across the United States were collected and analyzed. Overall resistance was found to be 92 %.

The researchers were very surprised at the speed with which the influenza strains develop the resistance. They feel that this is due to the widespread, over-the-counter and unregulated use of the drugs in other countries.

Tamiflu (oseltamivir) and Relenza (zanamivir) both the antiviral drugs belong to the neuraminidase inhibitor class of antivirals. The virus has not developed resistance against this class of drugs and hence can be used. But researchers fear that people will be using them more and might begin using them inappropriately and, with increased and inappropriate use, this will also become ineffective against the virus.

The researchers feel that there is an increased necessity for more energy and resources to be devoted to develop new antiviral drugs. In the end they conclude by saying that vaccines are the true way to protect oneself against influenz a.


Related medicine news :

1. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
2. Hope for Chemo-Resistant Leukemia Patients
3. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
4. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
5. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
6. Treatment Resistant Tumors Can Be Targeted Better Using Botox
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. ‘Drug Resistant TB’ Rattles the Union Ministy
9. Malaria Resistant Mosquitoes Could Help In Combating Malaria
10. Tumor Resistant Mice Point To Novel Cancer Treatments
11. Mad-Cow Resistant Calf Cloned in China
Post Your Comments:

(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... Manalapan, N.J., has created the COUCH BUDDY. "I conceived of this design due to ... more comfort for couch users. It promotes relaxation and convenience, as well as increases ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
Breaking Medicine Technology: